Rapporteurs : Pr Lysiane Richert

télécharger 1.72 Mb.
titreRapporteurs : Pr Lysiane Richert
date de publication20.11.2017
taille1.72 Mb.
b.21-bal.com > droit > Rapport
1   ...   24   25   26   27   28   29   30   31   32

Tsao CC, Coulter SJ, Chien A, Luo G, Clayton NP, Maronpot R, Goldstein JA and Zeldin DC

Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio and stereoselactive products.

J. Pharmacol. Exp. Ther. 2001 ; 299 : 39-47.
Tsuneoka Y, Matsuo Y, Okuyama E, Watanabe Y, Ichikawa Y.

Genetic analysis of the cytochrome P-45OIIC18 (CYP2C18) gene and a novel member of the CYP2C subfamily.

FEBS Lett. 1996 ; 384 : 281-284.
Tzameli I, Pissios P, Schuetz EG, Moore DD.

The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR.

Mol Cell Biol. 2000 ; 20 : 2951-2958.
Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, Negishi M.

Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital.

Mol Pharmacol. 2002 ; 61 : 1-6.
Umehara K, Shimokawa Y, Miyamoto G. Related Articles, Links

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.

Biol Pharm Bull. 2002 ; 25 : 682-685.
Usui T, Saitoh Y, Komada F.

Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor.

Biol Pharm Bull. 2003 ; 26 : 510-517.
Vane JR, Bakhle YS, Botting RM.

Cyclooxygenases 1 and 2.

Annu Rev Pharmacol Toxicol. 1998 ; 38 : 97-120.
Vaughan CJ, Murphy MB, Buckley BM.

Statins do more than just lower cholesterol.

Lancet. 1996 ; 348 : 1079-1082.
Villard PH, Seree E, Lacarelle B, Therene-Fenoglio MC, Barra Y, Attolini L, Bruguerole B, Durand A, Catalin J. Related Articles, Links

Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung.

Biochem Biophys Res Commun. 1994 ; 202 : 1731-1737.
Vincent L, Soria C, Mirshahi F, Opolon P, Mishal Z, Vannier JP, Soria J, Hong L. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models.

Arterioscler Thromb Vasc Biol. 2002 ; 22 : 623-629.
Voelkel NF, Tuder RM, Wade K, Hoêr M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

J. Clin. Invest. 1996 ; 97 : 2491-2498.
Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR.

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.

Clin Pharmacol Ther. 2000 ; 68 : 82-91.
Watkins PB.

The barrier function of CYP3A4 and P-glycoprotein in the small bowel.

Adv Drug Deliv Rev. 1997 ; 27 : 161-170.
Wang MH, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, Schwartzman ML.

Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein.

Arch Biochem Biophys. 1996 ; 336 : 240-250.
Wang SL, Lee H, Chen KW, Tsai KJ, Chen CY and Lin P

Cytochrome P4502E1 genetic polymorphisms and lung cancer in a taiwanese population

Lung cancer. 1999 ; 26 : 27-34
Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M.

CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR.

Am J Physiol Regul Integr Comp Physiol. 2001 ; 280 : R255-R261.
Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ.

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.

Drug Metab Dispos. 2002 (a) ; 30 : 1352-1356.
Wang JF, Yang Y, Sullivan MF, Min J, Cai J, Zeldin DC, Xiao YF, Morgan JP.

Induction of cardiac cytochrome p450 in cocaine-treated mice.

Exp Biol Med (Maywood). 2002 (b) ; 227 : 182-188.
Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE.

Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes.

Atherosclerosis. 2002 (c) ; 162 : 391-397.
Wang MH, Smith A, Zhou Y, Chang HH, Lin S, Zhao X, Imig JD, Dorrance AM.

Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.

Hypertension. 2003 (a) ; 42 : 594-599.

Wang XL, Raveendran M, Wang J.

Genetic influence on cigarette-induced cardiovascular disease.

Prog Cardiovasc Dis. 2003 (b) ; 45 : 361-382.

Warren GW, van Ess PJ, Watson AM, Mattson MP, Blouin RA.

Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.

J Interferon Cytokine Res. 2001 ; 21 : 821-826.
Waxman DJ.

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

Arch Biochem Biophys. 1999 ; 369 : 11-23.
Weksler BB, Eldor A, Falcone D, Levin RI, Jaffe EA and Minick CR.

(1982) in cardiavascular pharmacology of prostaglandins.

(Herman, AG, Vanhoutte PM, Denolin H and Goossens A, eds) pp137-148, Raven Press, New York.
Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ.

Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively.

Drug Metab Dispos. 2002 ; 30 : 631-635.
Westlind A, Lofberg L, Tindberg N, Andersson TB, Ingelman-Sundberg M.

Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region.

Biochem Biophys Res Commun. 1999 ; 259 : 201-205.
Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, Schuermann WH, Thilly WG, Olson DE, Hammersley JR, Crespi CL, Utell MJ.

Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.

Am J Respir Cell Mol Biol. 1997 ; 17 : 114-124.
Wong NA, Rae F, Simpson KJ, Murray GD, Harrison DJ.

Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Mol Pathol. 2000 ; 53 : 88-93.
Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD

Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells

J.Cardiovasc. Pharmacol. 1998 ; 31 : S348-350
Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, Warner TD

Endothelin-1 is induced by cytokines in human vascular smooth muscle cells : evidence for intracellular endothelin-converting enzyme.

Mol. Pharmacol. 1999; 55 : 902-909.
Woodside KJ, Hu M, Burke A, Murakami M, Pounds LL, Killewich LA, Daller JA, Hunter GC. Related Articles, Links

Morphologic characteristics of varicose veins: possible role of metalloproteinases.

J Vasc Surg. 2003 ; 38 : 162-169.
Wrighton SA, Ring BJ, Watkins PB, VandenBranden M.

Identification of a polymorphically expressed member of the human cytochrome P-450III family.

Mol Pharmacol. 1989 ; 36 : 97-105.

Wrighton SA, Schuetz EG, Thummel KE, Shen DD, Korzekwa KR, Watkins PB.

The human CYP3A subfamily: practical considerations.

Drug Metab Rev. 2000 ; 32 : 339-361.
Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic epoxygenase highly expressed in heart.

J. Biol.Chem. 1996 ; 271 : 3460- 3468.
Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, Zeldin DC.

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.

J Biol Chem. 1997 ; 272 : 12551-12559.
Xiang S, Parsons HK, Murray M.

Identification of a novel transcriptional silencer in the protein-coding region of the human CYP2C9 gene.

Gene. 1998 ; 209 : 123-129.
Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH.

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.

J Pharmacol Exp Ther. 1997 ; 281 : 604-609.
Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM.

Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.

Genes Dev. 2000 ; 14 : 3014-3023.
Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, Evans RM.

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

Proc Natl Acad Sci U S A. 2001 ; 98 : 3375-3380.
Xing D, Miller A, Novak L, Rocha R, Chen YF, Oparil S.

Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury.

Circulation. 2004 ; 109 : 234-241.
Yamada H, Dahl ML, Lannfelt L, Viitanen M, Winblad B, Sjoqvist F.

CYP2D6 and CYP2C19 genotypes in an elderly Swedish population.

Eur J Clin Pharmacol 1998 ; 54 : 479-481.
Yamakoshi Y, Kishimoto T, Sugimura K, Kawashima H.

Human prostate CYP3A5: identification of a unique 5'-untranslated sequence and characterization of purified recombinant protein.

Biochem Biophys Res Commun. 1999 ; 260 : 676-681.
Yamamoto S, Kusonose E, Ogita K, Kaku M, Ichihara K and Kusunose M,

Role of cytochrome P450 in co-hydroxylation of prostaglandins,

J. Biochem (Tokyo). 1984 ; 96 : 593-603.
Yamazaki H, Shimada T.

Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.

Xenobiotica. 1999 ; 29 : 231-241.
Yang CS, Yoo JS, Ishizaki H, Hong JY.

Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation.

Drug Metab Rev. 1990 ; 22 : 147-159.
Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, Zeldin DC.

Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells.

Mol Pharmacol. 2001 ; 60 : 310-320.
Yasar U, Eliasson E, Forslund-Bergengren C, Tybring G, Gadd M, Sjoqvist F, Dahl ML.

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.

Eur J Clin Pharmacol. 2001 ; 57 : 729-735.
Yasar U, Bennet AM, Eliasson E, Lundgren S, Wiman B, De Faire U, Rane A.

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

Pharmacogenetics. 2003 ; 13 : 715-720.
Yokomizo T, Izumi T, Shimizu T

Leukotriene B4 : metabolism and signal transduction.

Arch. Biochem. Biophys. 2001 ; 385 : 231-241.
Yu M, McAndrew RP, Al-Saghir R, Maier KG, Medhora M, Roman RJ, Jacobs ER.

Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries.

J Appl Physiol. 2002 ; 93 : 1391-1399.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V.

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Atherosclerosis. 2000 ; 148 : 209-214.
Yun CH, Shimada T, Guengerich FP.

Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene.

Cancer Res. 1992 ; 52 : 1868-1874.
ZeldinDC, Dubois RN Falk JR, Capdevila JH

Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.

Arch Biochem Biophys. 1995 ; 322 : 76-86.
Zeldin DC, Moomaw CR, Jesse N et al.

Biochemical characterization of the human liver cytochrome P450 arachidonic acid pathway

Arch. Biochem. Biophys. 1996 ; 330 : 87-96.
Zelko I, Negishi M.

Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes.

Biochem Biophys Res Commun. 2000 ; 277 : 1-6.
Zhang X, Chen L, Hardwick JP.

Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by

peroxisomal proliferators and retinoic acid in HepG2 cells.

Arch Biochem Biophys. 2000(a) ; 378 : 364-376.
Zhang X and Hardwick JP

Regulation of CYP4F2 leukotriène B4 w-hydroxylase by retinoic acids in HepG2 cells

Biochem. Biophys. Res. Com. 2000(b) ; 279 : 864-871.
Zhao W, Parrish AR, Ramos KS.

Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells.

In Vitro Cell Dev Biol Anim. 1998 ; 34 : 671-673.
Zhao XJ, Jones DR, Wang YH, Grimm SW, Hall SD. Related Articles, Links

Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.

Xenobiotica. 2002 ; 32 : 863-878.
Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD.

Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.

Hypertension. 2003 ; 41 : 709-714.
Zhu D, Effros RM, Harder DR, Roman RJ, Jacobs ER.

Tissue sources of cytochrome P450 4A and 20-HETE synthesis in rabbit lungs.

Am J Respir Cell Mol Biol. 1998 ; 19 : 121-128.
Zhu D, Bousamra M II, Zeldin DC, Falck JR, Townsley M, Harder DR, Roman RJ, and Jacobs ER. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. Am J Physiol Lung Cell Mol Physiol. 2000 ; 278 : L335-L343.
Zhu D, Zhang C, Medhora M, Jacobs ER.

CYP4A mRNA, protein, and product in rat lungs : novel localization in vascular endothelium. J Appl Physiol. 2002 ; 93 : 330-337.
Zuber R, Modriansky M, Dvorak Z, Rohovsky P, Ulrichova J, Simanek V, Anzenbacher P.

Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities.

Phytother Res. 2002 ; 16 : 632-638.
Zweier JL, Kuppusamy P, Gorman-Thomson S, Klunk D, Lutty GA.

Measurement and characterization of free radical generation in reoxygenated human endothelial cells.

Am. J. Physiol. 1994 ; 266 : C700-C708.

1   ...   24   25   26   27   28   29   30   31   32


Rapporteurs : Pr Lysiane Richert iconRapporteurs

Rapporteurs : Pr Lysiane Richert iconRapporteurs

Rapporteurs : Pr Lysiane Richert iconRapporteurs

Rapporteurs : Pr Lysiane Richert iconRapporteurs

Rapporteurs : Pr Lysiane Richert iconRapporteurs : Madame Emmanuelle reynaud

Rapporteurs : Pr Lysiane Richert iconRapporteurs : Professeur Bruno levy (Nancy)

Rapporteurs : Pr Lysiane Richert iconRapporteurs
«kmp girls» qui se reconnaitront ici et à Bruno Delépine qui me fait l’honneur de participer au jury de la thèse

Tous droits réservés. Copyright © 2016